BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38020352)

  • 1. Universal test and treat in Cameroon: a comparative retrospective analysis of mortality and loss to follow-up before and after a strategic change in approach to HIV care.
    Bekolo CE; Ndeso SA; Moifo LL; Mangala N; Yimdjo TD; Ateudjieu J; Kouanfack C; Djam A; Tabah EN; Whegang S; Mapa-Tassou C; Tendongfor N; Nsagha DS; Choukem SP
    Pan Afr Med J; 2023; 45():191. PubMed ID: 38020352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of the Universal Test and Treat policy uptake on CD4 count testing and incidence of opportunistic infections among people living with HIV infection in Cameroon: a retrospective analysis of routine data.
    Bekolo CE; Ndeso SA; Gougue CP; Moifo LL; Mangala N; Tchendjou P; Mboh E; Ateudjieu J; Tendongfor N; Nsagha DS; Halle-Ekane GE; Choukem SP
    Dialogues Health; 2023 Dec; 2():100120. PubMed ID: 38515498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attrition in HIV care following HIV diagnosis: a comparison of the pre-UTT and UTT eras in South Africa.
    Onoya D; Hendrickson C; Sineke T; Maskew M; Long L; Bor J; Fox MP
    J Int AIDS Soc; 2021 Feb; 24(2):e25652. PubMed ID: 33605061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retention on antiretroviral therapy during Universal Test and Treat implementation in Zomba district, Malawi: a retrospective cohort study.
    Alhaj M; Amberbir A; Singogo E; Banda V; van Lettow M; Matengeni A; Kawalazira G; Theu J; Jagriti MR; Chan AK; van Oosterhout JJ
    J Int AIDS Soc; 2019 Feb; 22(2):e25239. PubMed ID: 30734510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the "universal test and treat" policy on the characteristics of persons registering for HIV care and initiating antiretroviral therapy in Uganda.
    Mugenyi L; Hansen CH; Mayaud P; Seeley J; Newton R; Nanfuka M; Abaasa A; Mugisha K; Etukoit M; Kaleebu P; Ruzagira E
    Front Public Health; 2023; 11():1187274. PubMed ID: 37361157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twelve months antiretroviral therapy retention among clients newly enrolled to care and treatment services in Geita Regin, Tanzania: does universal test and treat matter?
    Masuke R; Kihaga Y; Mashala M; Ndalio S; Sukari O; Panga O
    Pan Afr Med J; 2023; 46():20. PubMed ID: 38035160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lost to follow up rate in the first year of ART in adults initiated in a universal test and treat programme: a retrospective cohort study in Ekurhuleni District, South Africa.
    Chauke P; Huma M; Madiba S
    Pan Afr Med J; 2020; 37():198. PubMed ID: 33505567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in mortality and loss to follow-up in HIV care at the Nkongsamba Regional hospital, Cameroon.
    Bekolo CE; Webster J; Batenganya M; Sume GE; Kollo B
    BMC Res Notes; 2013 Dec; 6():512. PubMed ID: 24308609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the test and treat policy on delays in antiretroviral therapy initiation among adult HIV positive patients from six clinics in Johannesburg, South Africa: results from a prospective cohort study.
    Onoya D; Sineke T; Hendrickson C; Mokhele I; Maskew M; Long LC; Fox M
    BMJ Open; 2020 Mar; 10(3):e030228. PubMed ID: 32213514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of universal test and treat on retention and mortality among people living with HIV-infection in Uganda: An interrupted time series analysis.
    Mugenyi L; Nanfuka M; Byawaka J; Agaba C; Mijumbi A; Kagimu D; Mugisha K; Shabbar J; Etukoit M
    PLoS One; 2022; 17(5):e0268226. PubMed ID: 35580126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of loss to follow-up among HIV positive patients receiving antiretroviral therapy in a test and treat setting: A retrospective cohort study in Masaka, Uganda.
    Kiwanuka J; Mukulu Waila J; Muhindo Kahungu M; Kitonsa J; Kiwanuka N
    PLoS One; 2020; 15(4):e0217606. PubMed ID: 32255796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of implementing universal and rapid HIV treatment on initiation of antiretroviral therapy and retention in care in Zambia: a natural experiment using regression discontinuity.
    Mody A; Sikazwe I; Namwase AS; Wa Mwanza M; Savory T; Mwila A; Mulenga L; Herce ME; Mweebo K; Somwe P; Eshun-Wilson I; Sikombe K; Beres LK; Pry J; Holmes CB; Bolton-Moore C; Geng EH
    Lancet HIV; 2021 Dec; 8(12):e755-e765. PubMed ID: 34656208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV Treatment Outcomes Among Patients Initiated on Antiretroviral Therapy Pre and Post-Universal Test and Treat Guidelines in South Africa.
    Hirasen K; Fox MP; Hendrickson CJ; Sineke T; Onoya D
    Ther Clin Risk Manag; 2020; 16():169-180. PubMed ID: 32184609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in access to viral load testing, incidence rates of viral load suppression and rebound following the introduction of the 'universal test and treat' guidelines in Cameroon: A retrospective follow-up analysis.
    Bekolo CE; Ndeso SA; Moifo LL; Mangala N; Ateudjieu J; Kouanfack C; Dzudie A; Thienemann F; Tendongfor N; Nsagha DS; Choukem SP
    PLOS Glob Public Health; 2024; 4(4):e0003042. PubMed ID: 38626049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of same-day antiretroviral therapy initiation in retention outcomes among people living with human immunodeficiency virus in Ethiopia: empirical evidence.
    Ahmed I; Demissie M; Worku A; Gugsa S; Berhane Y
    BMC Public Health; 2020 Nov; 20(1):1802. PubMed ID: 33243185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of the observed high prevalence of loss to follow-up in ART-experienced adult PLHIV: a retrospective longitudinal cohort study in the Tanga Region, Tanzania.
    Mushy SE; Mtisi E; Mboggo E; Mkawe S; Yahya-Malima KI; Ndega J; Ngalesoni F; Muya A
    BMC Infect Dis; 2023 Feb; 23(1):92. PubMed ID: 36788523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss to follow-up in "test and treat era" and its predictors among HIV-positive adults receiving ART in Northwest Ethiopia: Institution-based cohort study.
    Bantie B; Seid A; Kerebeh G; Alebel A; Dessie G
    Front Public Health; 2022; 10():876430. PubMed ID: 36249247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of reduced treatment adherence among HIV infected paediatric and adolescent populations in Nairobi at the onset of the UNAIDS Universal Test and Treat Program.
    Kabogo J; Muniu E; Wamunyokoli F; Musoke R; Songok E
    BMC Res Notes; 2018 Feb; 11(1):134. PubMed ID: 29452597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High rates of loss to follow-up during the first year of pre-antiretroviral therapy for HIV patients at sites providing pre-ART care in Nigeria, 2004-2012.
    Agolory SG; Auld AF; Odafe S; Shiraishi RW; Dokubo EK; Swaminathan M; Dalhatu I; Onotu D; Abiri O; Debem H; Bashorun A; Ellerbrock TV
    PLoS One; 2017; 12(9):e0183823. PubMed ID: 28863160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Healthcare provider perceptions on the implementation of the universal test-and-treat policy in South Africa: a qualitative inquiry.
    Nicol E; Mehlomakulu V; Jama NA; Hlongwa M; Basera W; Pass D; Bradshaw D
    BMC Health Serv Res; 2023 Mar; 23(1):293. PubMed ID: 36978086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.